Literature DB >> 8053020

Artemisinin: current status.

N J White1.   

Abstract

The compounds derived from the Chinese medicinal plant qinghao (Artemisia annua) are the most rapidly acting of all antimalarial drugs. They are effective when given parenterally, orally or by suppository. No serious adverse effect has yet been reported in humans. The artemisinin derivatives already have an established role in the treatment of multi-drug resistant falciparum malaria, but their wider use will depend on the results of current mortality and toxicity studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8053020     DOI: 10.1016/0035-9203(94)90459-6

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  17 in total

1.  Establishment of an in vitro screening model for neurodegeneration induced by antimalarial drugs of the artemisinin-type..

Authors:  G Schmuck; R K Haynes
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 2.  Safety assessment of peroxide antimalarials: clinical and chemical perspectives.

Authors:  B K Park; P M O'Neill; J L Maggs; M Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 3.  The role of plant-derived drugs and herbal medicines in healthcare.

Authors:  P A De Smet
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 4.  Artemisinin derivatives for treating uncomplicated malaria.

Authors:  H M McIntosh; P Olliaro
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 5.  Current status of malaria and potential for control.

Authors:  R S Phillips
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

6.  Artemether shows promising female schistosomicidal and ovicidal effects on the Egyptian strain of Schistosoma mansoni after maturity of infection.

Authors:  Rashad Abdul-Ghani; Naguiba Loutfy; Manal Sheta; Azza Hassan
Journal:  Parasitol Res       Date:  2010-11-25       Impact factor: 2.289

7.  Multiple dose study of interactions between artesunate and artemisinin in healthy volunteers.

Authors:  S Q Zhang; T N Hai; K F Ilett; D X Huong; T M Davis; M Ashton
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

8.  Development and evaluation of anti-malarial bio-conjugates: artesunate-loaded nanoerythrosomes.

Authors:  Jaya Agnihotri; Shubhini Saraf; Sobhna Singh; Papiya Bigoniya
Journal:  Drug Deliv Transl Res       Date:  2015-10       Impact factor: 4.617

Review 9.  Artesunate. A review of its pharmacology and therapeutic efficacy in the treatment of malaria.

Authors:  L B Barradell; A Fitton
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

10.  First assessment in humans of the safety, tolerability, pharmacokinetics, and ex vivo pharmacodynamic antimalarial activity of the new artemisinin derivative artemisone.

Authors:  Johannes Nagelschmitz; Barbara Voith; Georg Wensing; Axel Roemer; Burkhard Fugmann; Richard K Haynes; Barbara M Kotecka; Karl H Rieckmann; Michael D Edstein
Journal:  Antimicrob Agents Chemother       Date:  2008-06-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.